Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 02-2017 | 02-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,513 | -39,366 | -16,777 | -7,991 | -4,846 |
| Depreciation Amortization | 2,320 | 2,333 | 2,085 | 1,916 | 1,837 |
| Income taxes - deferred | 246 | N/A | N/A | -98 | N/A |
| Accounts receivable | 581 | -620 | -432 | 178 | 36 |
| Accounts payable and accrued liabilities | -3,389 | 7,444 | 3,821 | 484 | 38 |
| Other Working Capital | -3,218 | 6,188 | 2,796 | 854 | -32 |
| Other Operating Activity | 6,022 | -766 | -1,260 | -79 | -2,077 |
| Operating Cash Flow | $-22,951 | $-24,787 | $-9,767 | $-4,737 | $-5,044 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,457 | -8,908 | -20 | 7,066 | 6,508 |
| PPE Investments | -319 | -534 | -355 | -1,909 | -212 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -70 |
| Other Investing Activity | 0 | 0 | 55 | 111 | 17 |
| Investing Cash Flow | $8,138 | $-9,442 | $-321 | $5,268 | $6,313 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,556 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 14,732 | 45,690 | 8,901 | 5,282 | 1 |
| Other Financing Activity | 7 | 0 | -2 | -14 | -2 |
| Financing Cash Flow | $13,183 | $45,690 | $8,899 | $5,268 | $-2 |
| Exchange Rate Effect | -1,001 | -1,013 | -20 | -44 | 50 |
| Beginning Cash Position | 16,871 | 6,423 | 7,624 | 2,308 | 1,006 |
| End Cash Position | 14,240 | 16,871 | 6,416 | 8,063 | 2,322 |
| Net Cash Flow | $-2,631 | $10,448 | $-1,209 | $5,755 | $1,317 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,951 | -24,787 | -9,767 | -4,737 | -5,044 |
| Capital Expenditure | -319 | -534 | -355 | -1,909 | -212 |
| Free Cash Flow | -23,270 | -25,321 | -10,122 | -6,646 | -5,256 |